161 related articles for article (PubMed ID: 33126611)
1. Comparative Genome Sequence Analyses of Geographic Samples of
Fan Y; Wang Y; Xu J
Microorganisms; 2020 Oct; 8(11):. PubMed ID: 33126611
[TBL] [Abstract][Full Text] [Related]
2. Genetic Analyses of Amphotericin B Susceptibility in
Fan Y; Korfanty GA; Xu J
J Fungi (Basel); 2021 Oct; 7(10):. PubMed ID: 34682281
[No Abstract] [Full Text] [Related]
3. Widespread amphotericin B-resistant strains of
Ashu EE; Korfanty GA; Samarasinghe H; Pum N; You M; Yamamura D; Xu J
Infect Drug Resist; 2018; 11():1549-1555. PubMed ID: 30288065
[TBL] [Abstract][Full Text] [Related]
4. Prior in vitro exposure to voriconazole confers resistance to amphotericin B in Aspergillus fumigatus biofilms.
Rajendran R; Mowat E; Jones B; Williams C; Ramage G
Int J Antimicrob Agents; 2015 Sep; 46(3):342-5. PubMed ID: 25979638
[TBL] [Abstract][Full Text] [Related]
5. Antifungal resistance in Aspergillus terreus: A current scenario.
Vahedi Shahandashti R; Lass-Flörl C
Fungal Genet Biol; 2019 Oct; 131():103247. PubMed ID: 31247322
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.
Abraham OC; Manavathu EK; Cutright JL; Chandrasekar PH
Diagn Microbiol Infect Dis; 1999 Jan; 33(1):7-11. PubMed ID: 9990469
[TBL] [Abstract][Full Text] [Related]
7. Identifying genetic variants associated with amphotericin B (AMB) resistance in
Chen MM; Shi GH; Dai Y; Fang WX; Wu Q
Front Genet; 2023; 14():1133593. PubMed ID: 37229189
[No Abstract] [Full Text] [Related]
8. Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.
Singh J; Rimek D; Kappe R
Mycoses; 2006 Mar; 49(2):96-103. PubMed ID: 16466441
[TBL] [Abstract][Full Text] [Related]
9. Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutations.
Sharma C; Nelson-Sathi S; Singh A; Radhakrishna Pillai M; Chowdhary A
Fungal Genet Biol; 2019 Nov; 132():103265. PubMed ID: 31465846
[TBL] [Abstract][Full Text] [Related]
10. Proteomic and transcriptomic analysis of Aspergillus fumigatus on exposure to amphotericin B.
Gautam P; Shankar J; Madan T; Sirdeshmukh R; Sundaram CS; Gade WN; Basir SF; Sarma PU
Antimicrob Agents Chemother; 2008 Dec; 52(12):4220-7. PubMed ID: 18838595
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo role of heat shock protein 90 in Amphotericin B resistance of Aspergillus terreus.
Blum G; Kainzner B; Grif K; Dietrich H; Zeiger B; Sonnweber T; Lass-Flörl C
Clin Microbiol Infect; 2013 Jan; 19(1):50-55. PubMed ID: 22515428
[TBL] [Abstract][Full Text] [Related]
12. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.
Lionakis MS; Lewis RE; Torres HA; Albert ND; Raad II; Kontoyiannis DP
Diagn Microbiol Infect Dis; 2005 May; 52(1):15-20. PubMed ID: 15878437
[TBL] [Abstract][Full Text] [Related]
13. Blocking Hsp70 enhances the efficiency of amphotericin B treatment against resistant Aspergillus terreus strains.
Blatzer M; Blum G; Jukic E; Posch W; Gruber P; Nagl M; Binder U; Maurer E; Sarg B; Lindner H; Lass-Flörl C; Wilflingseder D
Antimicrob Agents Chemother; 2015 Jul; 59(7):3778-88. PubMed ID: 25870060
[TBL] [Abstract][Full Text] [Related]
14. [A pharmacodynamics study of an intravitreal amphotericin B drug delivery system for the treatment of experimental Aspergillus fumigatus endophthalmitis].
Yang X; Dong XG; Liu AM; Sun SY; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2007 Jun; 43(6):546-53. PubMed ID: 17897534
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole.
Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga M; Alonso R; del Valle O; Rodriguez V; Arévalo MP; Salgado J; Martin-Mazuelos E; Bornay-Llinares FJ; del Palacio A; Cuétara M; Gasser I; Hernández-Molina JM; Pemán J
Chemotherapy; 2000; 46(4):235-44. PubMed ID: 10859429
[TBL] [Abstract][Full Text] [Related]
16.
Seyedmousavi S; Mouton JW; Melchers WJG; Verweij PE
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416540
[TBL] [Abstract][Full Text] [Related]
17. Amphotericin B Resistance in Aspergillus terreus Is Overpowered by Coapplication of Pro-oxidants.
Blatzer M; Jukic E; Posch W; Schöpf B; Binder U; Steger M; Blum G; Hackl H; Gnaiger E; Lass-Flörl C; Wilflingseder D
Antioxid Redox Signal; 2015 Dec; 23(18):1424-38. PubMed ID: 26054424
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies.
Colozza C; Posteraro B; Santilli S; De Carolis E; Sanguinetti M; Girmenia C
Int J Antimicrob Agents; 2012 May; 39(5):440-3. PubMed ID: 22429723
[TBL] [Abstract][Full Text] [Related]
19. Global Population Genetic Analysis of
Ashu EE; Hagen F; Chowdhary A; Meis JF; Xu J
mSphere; 2017; 2(1):. PubMed ID: 28168221
[No Abstract] [Full Text] [Related]
20. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
Walsh TJ; Petraitis V; Petraitiene R; Field-Ridley A; Sutton D; Ghannoum M; Sein T; Schaufele R; Peter J; Bacher J; Casler H; Armstrong D; Espinel-Ingroff A; Rinaldi MG; Lyman CA
J Infect Dis; 2003 Jul; 188(2):305-19. PubMed ID: 12854088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
